11.3 Gastroesophageal Reflux (GER)

Immediate Safety Rules

These are not routine reflux until proven otherwise

Bilious emesis, persistent projectile vomiting, abdominal distension, bloody stool, shock, lethargy, fever, metabolic acidosis, or poor perfusion requires urgent evaluation — not a reflux diagnosis.
Reflux alone is usually not the cause of apnea of prematurity; do not treat apnea/bradycardia/desaturation with acid suppression unless the full clinical picture supports true GERD or aspiration disease.
Healthy preterm infants should not routinely receive H2 blockers, proton pump inhibitors, metoclopramide, bethanechol, domperidone, or erythromycin for ordinary reflux symptoms.
Commercial thickeners should not be used for routine NICU reflux management in preterm or former-preterm infants; thickening for proven aspiration/dysphagia is a separate multidisciplinary decision. Baylor Ed. 33 goes further: no commercial thickening agent is to be added to human milk or formula for any infant in its Level 2–4 NICUs, except within an IRB-approved research protocol.

Bedside purpose

Prevent overdiagnosis and overtreatment of common neonatal reflux while rapidly identifying infants with true disease or an alternative diagnosis.
Standardize safe first-line management: review feeds, growth, tube position, respiratory status, and red flags before ordering tests or starting medication.
Reduce avoidable harm from routine acid suppression, prokinetic agents, and commercial thickening products in preterm or former-preterm infants.

1. Core Bedside Messages

Clinical Question	Guideline Answer
Is GER common?	Yes. GER is the passage of gastric contents into the esophagus and is common in infants. In preterm infants, reflux episodes are often non-acid and improve with maturation.
When is it GERD?	GERD is suspected when reflux causes troublesome symptoms that impair feeding, growth, respiratory stability, comfort, development, or causes complications such as esophagitis or aspiration.
Does GER cause apnea?	Usually no. Baylor, Belize, and AAP guidance emphasize that temporal linkage between GER and apnea of prematurity is usually absent or weak.
Should every spitting infant be treated?	No. If the infant is growing, feeding, comfortable enough, and has no red flags, reassurance and observation are preferred.
What is first-line care?	Confirm there is no dangerous alternative diagnosis; avoid overfeeding; adjust feed volume, frequency, and duration; support human milk; check tube position; and monitor growth.
What is the main medication rule?	Avoid routine acid suppression and prokinetics. Consider medication only for selected high-risk infants with objective complications or specialist-directed treatment goals.

2. Definitions and Differentiation

Term	NICU Definition	Typical Action
Physiologic GER	Passage of gastric contents into the esophagus with or without regurgitation; common, often non-acid, and usually improves with maturation.	Reassure, avoid overfeeding, monitor growth and symptoms.
GERD	Reflux that causes troublesome symptoms or complications affecting daily functioning, feeding, growth, airway stability, or mucosal injury.	Evaluate for severity, alternative diagnoses, feeding problems, dysphagia, cow milk protein allergy, and specialist needs.
Happy spitter	Effortless, non-projectile regurgitation in a well-appearing infant with normal growth and no red flags.	No medication or diagnostic testing; educate caregivers.
Feeding intolerance	Emesis, distension, residual concerns, poor growth, or respiratory changes around feeds; may reflect prematurity-related dysmotility rather than GERD.	Assess abdominal exam, stool, perfusion, feed type/volume, osmolarity, fortification, tube position, and NEC risk.
Aspiration / dysphagia	Airway penetration or aspiration from impaired suck-swallow-breathe coordination or anatomic/neurologic disease.	Do not treat as simple reflux; involve speech/feeding therapy and consider instrumental swallow evaluation.

3. Initial Assessment: Do Not Start With Medication

Minimum Documentation Before Labeling GERD

Age, gestational age, postmenstrual age, birth weight/current weight, growth velocity, and feeding maturity.
Detailed feeding history: human milk/formula, fortification, osmolality concerns, total mL/kg/day, kcal/oz, bolus vs. continuous, feed duration, tube position, nipple flow, respiratory support during feeds.
Symptom pattern: timing relative to feeds, effortless regurgitation vs. forceful vomiting, bilious vs. non-bilious, blood, pain behaviors, arching, choking, cough, desaturation, bradycardia, or recurrent pneumonia.
Full exam: abdominal distension/tenderness, stool pattern, hydration/perfusion, respiratory work, airway noise, neurologic tone, congenital anomalies, and signs of sepsis or NEC.

Red Flag Assessment

Red Flag	Why It Matters	Immediate Action
Bilious emesis	Possible malrotation/volvulus or obstruction.	Stop feeds; urgent surgical/radiology evaluation.
Projectile persistent vomiting	Possible pyloric stenosis or obstruction.	Check electrolytes/glucose; abdominal ultrasound or surgical evaluation as appropriate.
Abdominal distension, bloody stool, acidosis, shock	NEC, SIP, sepsis, obstruction, or intestinal ischemia.	NPO, decompression, cultures/labs, imaging, antibiotics, surgery consult.
Poor weight gain or feeding refusal	GERD is possible, but inadequate intake, milk protein allergy, dysphagia, cardiac/respiratory disease, and metabolic disease must be assessed.	Dietitian/feeding review; consider GI/SLP depending on severity.
Apnea / brady / desaturation only	Reflux is commonly blamed but usually not causal.	Evaluate apnea of prematurity, anemia, sepsis, respiratory disease, airway obstruction, feeding coordination, and monitor-event timing.
Hematemesis or anemia	Possible esophagitis, gastritis, swallowed maternal blood, coagulopathy, stress injury, or vascular lesion.	Examine, review medications, consider labs/GI input.

4. Diagnostic Testing

Test	Role in NICU Reflux Evaluation	Important Limitation
No test	Appropriate for thriving infants without red flags.	Observation must include growth and symptom trajectory.
Abdominal/chest radiograph	Use when evaluating tube position, obstruction, NEC, aspiration complications, or another clinical reason.	Do not use routine radiography solely to prove reflux.
Upper GI contrast study	Useful to exclude malrotation, anatomic obstruction, stricture, or postsurgical anatomy concerns.	A reflux event during the study does not diagnose GERD severity.
Ultrasound	Useful for pyloric stenosis or selected abdominal diagnoses.	Not a routine GERD diagnostic test.
pH probe or pH-impedance	May help correlate acid/non-acid reflux events with symptoms in complex cases.	Limited utility in routine preterm reflux; requires specialist interpretation.
Endoscopy / biopsy	Consider when severe esophagitis, bleeding, strictures, eosinophilic disease, or complex surgical disease is suspected.	Not first-line for ordinary regurgitation.
Swallow study / VFSS / FEES	Use when choking, coughing, wet respirations, recurrent desaturation during oral feeds, suspected aspiration, vocal cord dysfunction, or complex airway disease is present.	Evaluates swallowing and aspiration risk, not ordinary gastric reflux.

5. Practical Management Algorithm

Step	Action	Proceed When…
1. Stabilize and exclude emergencies	If red flags are present, stop feeds and evaluate for NEC, obstruction, sepsis, metabolic disease, pyloric stenosis, malrotation, or aspiration.	Only resume reflux pathway after dangerous diagnoses are excluded or treated.
2. Reassure if physiologic	For thriving infants with effortless regurgitation, provide caregiver education and avoid medications/tests.	Symptoms do not affect growth, feeding, respiratory status, or development.
3. Optimize feeding mechanics	Avoid overfeeding; consider smaller volumes more often, slower gavage duration, nipple-flow adjustment, burping/handling strategy, and tube-position check.	Monitor weight, intake, work of breathing, and symptom frequency.
4. Support human milk	Encourage breast milk and lactation support. If formula-fed or cow milk protein allergy is suspected, consider a 2–4 week supervised hydrolysate/amino-acid trial or maternal dairy elimination for breastfeeding mothers.	Persistent symptoms despite careful feeding optimization, especially with eczema, blood/mucus in stool, irritability, or poor growth.
5. Avoid routine thickening	Do not use commercial thickeners for routine GER in preterm/former-preterm infants. If aspiration is documented, decide with SLP/OT, dietitian, neonatology, and GI using local safety policy.	There is a true swallowing/aspiration indication, not simple spitting.
6. Specialist escalation	Consult GI/aerodigestive/surgery for severe symptoms, esophagitis, recurrent aspiration, complex anatomy, neurologic disease, CDH/EA/TEF, intestinal failure, or persistent failure to thrive.	Objective complications or failure of conservative pathway.
7. Medication only if justified	Use short, goal-directed acid suppression only for selected infants with specialist-supported GERD complications; stop if no clear benefit.	Document indication, planned duration, adverse-effect monitoring, and weaning plan.

6. Non-Pharmacologic Management Details

Intervention	How to Use Safely	Avoid / Caution
Feed volume & frequency	Review total daily fluid and calorie goals. Reduce excessive bolus volume and consider smaller/more frequent feeds when clinically appropriate.	Do not compromise growth or hydration.
Feed duration	For gavage-fed infants with emesis, lengthening feed duration can help dysmotility-related symptoms.	Avoid indefinite very prolonged feeds without nutrition/growth review.
Positioning while monitored	In the NICU, certain positions may reduce reflux events in selected monitored infants.	Do not translate monitored prone/lateral positioning into home sleep recommendations.
Discharge sleep position	Use supine sleep on a flat, non-inclined surface once positional stability and discharge preparation begin.	Avoid head-of-bed elevation, wedges, sleep positioners, or prone sleeping at home for reflux.
Thickened feeds	Only for carefully selected infants when aspiration/dysphagia is proven and safer alternatives are insufficient.	Avoid commercial xanthan-gum-type thickeners in preterm/former-preterm infants unless local multidisciplinary policy explicitly supports use for a defined indication.
Cow milk protein strategy	Use a 2–4 week supervised trial of extensively hydrolyzed or amino-acid formula, or maternal dairy elimination for breastfed infants, when allergy mimics GERD.	Do not keep restrictive diets/formulas indefinitely without reassessment and reintroduction planning.
Transpyloric feeds	Consider for severe aspiration risk, severe respiratory compromise linked to feeds, or complex surgical/anatomic disease after specialist review.	Not routine therapy for ordinary GER.

Source-difference note: thickening and positioning

Baylor takes a restrictive approach: no commercial thickening agent in Level 2, 3, or 4 nurseries for routine GER because of adverse events and NEC concern in preterm/former-preterm infants.
West Midlands allows a trial of thickened feeds in babies older than 34 weeks gestation, and advises not to combine Carobel and Gaviscon because the milk may become too thick.
Neonatology Academy synthesis: avoid thickeners for routine preterm GER; reserve thickening for documented dysphagia/aspiration under local multidisciplinary policy, not for ordinary spitting.

7. Pharmacologic Stewardship

If an agent is genuinely indicated, these are the ones Baylor Ed. 33 names

Famotidine (Pepcid) — H2 receptor antagonist, available orally and intravenously, and compatible as an additive with parenteral nutrition.
Lansoprazole (Prevacid) — PPI available as oral suspension, capsule and disintegrating tablet. Use the oral suspension while the infant is in the NICU where possible; it is also the preferred outpatient option.
Pantoprazole (Protonix) — the intravenous PPI. Not compatible with parenteral nutrition.
The caution that governs all of them: H2 receptor antagonists in neonates are associated with increased NEC and gram-negative bacteraemia. That evidence does not exist for PPIs, but since the end result — a raised gastric pH — is the same, extend the same caution to PPIs.
Who is actually at risk of true GERD: infants with congenital diaphragmatic hernia, tracheo-oesophageal fistula or oesophageal atresia repair, abdominal wall defects and intestinal failure. These infants often have genuine oesophageal and GI dysmotility with real risk of oesophagitis, gastritis and aspiration, and it is in this subset that acid suppression as adjunctive therapy relieves symptoms and promotes healing. Transpyloric feeding or fundoplication may be needed in the most severe cases.
Metoclopramide carries an FDA black-box warning for chronic use because of tardive dyskinesia, which is rarely reversible and has no known treatment — even after the drug is stopped.

Medication Class	Why Routine Use Is Discouraged	When It May Be Considered
H2 receptor antagonists	Limited benefit for typical preterm reflux symptoms; neonatal literature associates gastric acid suppression with infection risk, NEC, and gram-negative bacteremia.	Selected infants with proven acid-mediated esophagitis or bleeding after specialist discussion.
Proton pump inhibitors	Symptoms in infants often do not improve, and acid suppression does not treat non-acid reflux or immature motility; infection-risk caution applies.	Short goal-directed trial for objectively suspected acid-mediated disease after GI review. Recent pharmacokinetic work on at least one PPI shows it is well tolerated and gives dose-related acid suppression in infants 1–24 months.
Metoclopramide	Efficacy is poor and neurologic adverse effects are concerning; Baylor strongly discourages routine use.	Rare specialist-directed use only when benefits clearly outweigh risk.
Bethanechol / domperidone	Insufficient neonatal efficacy/safety for routine reflux treatment.	Generally avoid; discuss with GI/aerodigestive team only in unusual motility cases.
Erythromycin	A prokinetic rather than reflux medication; tachyphylaxis, pyloric stenosis concern, QT/drug-interaction issues.	May be considered after 14 days of life for significant dysmotility/feeding intolerance, not routine GER. Overlaps with Chapter 11.4 (dysmotility).
Alginates	Can thicken feeds and increase sodium/aluminum exposure depending on product; local product differences matter.	May be used in some UK pathways after thickener trial; should not be combined with thickener; avoid as routine NICU preterm therapy unless local policy supports it.

Clinical caution: medication should have a written target, stop date, and monitoring plan

If symptoms do not clearly improve, stop therapy and revisit the diagnosis rather than escalating dose or adding a second acid-suppressive drug.

8. Special Populations

Population	GER-Related Concern	Recommended Approach
Preterm infant with apnea/brady/desaturation	GER is often blamed, but causal linkage is usually absent.	Evaluate apnea of prematurity, anemia, infection, respiratory disease, feeding coordination, airway obstruction, and monitor-event timing. Avoid empiric acid suppression.
BPD or chronic respiratory support	Emesis/aspiration can worsen respiratory status, but reflux is not always the cause.	Assess feeding safety, swallow coordination, aspiration risk, caloric density, and respiratory reserve; consider aerodigestive review for severe cases.
CDH, repaired EA/TEF, abdominal wall defect, intestinal failure	Higher risk of dysmotility, esophagitis, aspiration, and poor growth.	Use individualized GI/surgery/dietitian pathway; consider acid suppression only with clear indication and follow-up.
Neurologic impairment or airway anomaly	High aspiration risk and poor coordination may mimic GERD.	Feeding therapy and swallow evaluation often matter more than reflux medication.
Poor growth despite feeding changes	Could reflect insufficient calories, malabsorption, milk protein allergy, cardiac/respiratory disease, or chronic illness.	Dietitian review, growth plan, targeted labs, and GI/specialist input.

9. Discharge and Parent Counseling

Counseling Topic	Parent-Friendly Message
Normal reflux	Many babies spit up. If the baby is feeding, growing, breathing comfortably, and has no warning signs, reflux usually improves with time.
When to seek urgent care	Green vomit, blood in vomit or stool, swollen belly, repeated forceful vomiting, lethargy, fever, poor perfusion, choking with color change, poor feeding, dehydration, or poor weight gain needs prompt medical review.
Safe sleep	For sleep at home: always supine, flat, and non-inclined. Do not use wedges, positioners, or prone sleeping for reflux.
Feeding plan	Give the exact feed volume, frequency, fortification, bottle/nipple plan, and what to do if vomiting worsens.
Medication plan	Avoid sending infants home on acid suppression without a specific diagnosis, target symptom, duration, and follow-up plan.
Follow-up	Arrange follow-up for persistent symptoms, poor growth, suspected cow milk protein allergy, aspiration/dysphagia, BPD, surgical history, or complex GI disease.

10. Unit Quality and Safety Metrics

Metric	Why It Matters
Percent of reflux-labeled infants with documented red-flag assessment	Reduces missed NEC, obstruction, sepsis, and aspiration disease.
Acid-suppressive medication days per 1,000 NICU patient-days	Tracks stewardship and avoidable exposure.
Percent of acid-suppression starts with documented stop date and indication	Prevents medication drift.
Commercial thickener exposure in preterm/former-preterm infants	Identifies a high-harm practice needing multidisciplinary review.
Discharge safe-sleep documentation for infants with reflux symptoms	Prevents unsafe home positioning.

11. Source Synthesis

Source	How It Was Used
Baylor 2025–2026	Primary chapter backbone: GER definition, limited relationship with apnea, documentation before treatment, supine flat sleep, avoidance of routine thickening/prokinetics, and medication cautions.
West Midlands 2025–2028	Added bedside definitions, history/exam approach, limited diagnostic testing, feeding modification, >34-week thickener pathway, cow milk protein trial, and parent reassurance.
Belize 2018–2021	Added pathophysiology, happy-spitter concept, common natural history, feeding adjustments, warning signs, apnea/BPD cautions, and follow-up triggers.
NASPGHAN/ESPGHAN 2018	Used for infant algorithm: history/exam, alarm signs, avoid overfeeding, thickening or breastfeeding support, cow milk protein strategy, GI referral, and cautious short medication trial only when needed.
AAP Clinical Reports	Used for preterm-specific caution: GER is common, often non-acid, not usually linked to apnea, and routine acid suppression/prokinetics have poor benefit and potential harm.

Key Takeaways — Chapter 11.3

GER is common and usually physiologic in preterm infants; most episodes are non-acid and resolve with maturation.
GERD requires troublesome symptoms or complications — a spitting infant who is growing and comfortable does not need medication.
Bilious emesis, abdominal distension, shock, bloody stool, and acidosis are red flags — not routine reflux; stop feeds and evaluate urgently.
GER does not usually cause apnea of prematurity; empiric acid suppression for apnea/bradycardia events is not supported.
First-line management is feeding optimization, human milk support, and growth monitoring — not medication or thickeners.
Commercial thickeners should not be used for routine GER in preterm/former-preterm infants; aspiration/dysphagia is a separate decision with SLP and dietitian involvement.
Acid suppression and prokinetics carry real risks in neonates; use only with a written indication, target, stop date, and follow-up plan.
Discharge means: supine flat sleep, written feeding plan, clear red-flag instructions, and no empiric medications without specific diagnosis and planned follow-up.

Selected References and Source Links

Baylor College of Medicine. Guidelines for Acute Care of the Neonate, Edition 33, 2025–2026. Chapter 6.5: Gastroesophageal Reflux.
West Midlands Neonatal Operational Delivery Network. Neonatal Guidelines 2025–2028. Gastro-oesophageal reflux disease (GORD).
Belize Ministry of Health. Neonatal Clinical Practice Guidelines 2018–2021. Gastro-oesophageal Reflux.
Rosen R, Vandenplas Y, Singendonk M, et al. Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: NASPGHAN/ESPGHAN. J Pediatr Gastroenterol Nutr. 2018;66(3):516–554. PMC Link
AAP Committee on Fetus and Newborn. Diagnosis and Management of Gastroesophageal Reflux in Preterm Infants. Pediatrics. 2018;142(1):e20181061. AAP Link
AAP Committee on Nutrition. Be cautious in using thickening agents for preemies. AAP News. 2011. AAP Link
FDA safety communication: Do not feed SimplyThick to premature infants. 2011. FDA.gov

Implementation note

This chapter is designed for education and guideline-building. Bedside use must follow local neonatal formulary, pharmacy compatibility, feeding-therapy policy, dietitian assessment, and specialist recommendations.